Major eosinophilia induced by subcutaneous apomorphine infusion: four cases
Identifieur interne : 000315 ( Istex/Corpus ); précédent : 000314; suivant : 000316Major eosinophilia induced by subcutaneous apomorphine infusion: four cases
Auteurs : X. Moisset ; A. Castrioto ; N. Vitello ; R. Lemal ; V. Fraix ; P. Krack ; F. DurifSource :
- European Journal of Neurology [ 1351-5101 ] ; 2013-07.
Url:
DOI: 10.1111/ene.12149
Links to Exploration step
ISTEX:DE52E18D4E1BCE34400449936B618278D795B35ALe document en format XML
<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title xml:lang="en">Major eosinophilia induced by subcutaneous apomorphine infusion: four cases</title><author><name sortKey="Moisset, X" sort="Moisset, X" uniqKey="Moisset X" first="X." last="Moisset">X. Moisset</name><affiliation><mods:affiliation>Clermont Université, Université d'Auvergne, CHU Clermont‐Ferrand, Service de Neurologie, CHU Gabriel Montpied, Clermont‐Ferrand, France</mods:affiliation></affiliation></author><author><name sortKey="Castrioto, A" sort="Castrioto, A" uniqKey="Castrioto A" first="A." last="Castrioto">A. Castrioto</name><affiliation><mods:affiliation>CHU Grenoble, Unité des Troubles du Mouvement, Pôle de Psychiatrie et de Neurologie, La Tronche, France</mods:affiliation></affiliation></author><author><name sortKey="Vitello, N" sort="Vitello, N" uniqKey="Vitello N" first="N." last="Vitello">N. Vitello</name><affiliation><mods:affiliation>Clermont Université, Université d'Auvergne, CHU Clermont‐Ferrand, Service de Neurologie, CHU Gabriel Montpied, Clermont‐Ferrand, France</mods:affiliation></affiliation></author><author><name sortKey="Lemal, R" sort="Lemal, R" uniqKey="Lemal R" first="R." last="Lemal">R. Lemal</name><affiliation><mods:affiliation>Clermont Université, Université d'Auvergne, CHU Clermont‐Ferrand, Service d'Hématologie clinique adulte et de Thérapie cellulaire, CREaT‐EA 7283, INSERM CIC‐501, CHU Estaing, Clermont‐Ferrand, France</mods:affiliation></affiliation></author><author><name sortKey="Fraix, V" sort="Fraix, V" uniqKey="Fraix V" first="V." last="Fraix">V. Fraix</name><affiliation><mods:affiliation>CHU Grenoble, Unité des Troubles du Mouvement, Pôle de Psychiatrie et de Neurologie, La Tronche, France</mods:affiliation></affiliation></author><author><name sortKey="Krack, P" sort="Krack, P" uniqKey="Krack P" first="P." last="Krack">P. Krack</name><affiliation><mods:affiliation>CHU Grenoble, Unité des Troubles du Mouvement, Pôle de Psychiatrie et de Neurologie, La Tronche, France</mods:affiliation></affiliation></author><author><name sortKey="Durif, F" sort="Durif, F" uniqKey="Durif F" first="F." last="Durif">F. Durif</name><affiliation><mods:affiliation>Clermont Université, Université d'Auvergne, CHU Clermont‐Ferrand, Service de Neurologie, CHU Gabriel Montpied, Clermont‐Ferrand, France</mods:affiliation></affiliation><affiliation><mods:affiliation>E-mail: fdurif@chu-clermontferrand.fr</mods:affiliation></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">ISTEX</idno><idno type="RBID">ISTEX:DE52E18D4E1BCE34400449936B618278D795B35A</idno><date when="2013" year="2013">2013</date><idno type="doi">10.1111/ene.12149</idno><idno type="url">https://api.istex.fr/document/DE52E18D4E1BCE34400449936B618278D795B35A/fulltext/pdf</idno><idno type="wicri:Area/Istex/Corpus">000315</idno><idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Corpus" wicri:corpus="ISTEX">000315</idno></publicationStmt><sourceDesc><biblStruct><analytic><title level="a" type="main" xml:lang="en">Major eosinophilia induced by subcutaneous apomorphine infusion: four cases</title><author><name sortKey="Moisset, X" sort="Moisset, X" uniqKey="Moisset X" first="X." last="Moisset">X. Moisset</name><affiliation><mods:affiliation>Clermont Université, Université d'Auvergne, CHU Clermont‐Ferrand, Service de Neurologie, CHU Gabriel Montpied, Clermont‐Ferrand, France</mods:affiliation></affiliation></author><author><name sortKey="Castrioto, A" sort="Castrioto, A" uniqKey="Castrioto A" first="A." last="Castrioto">A. Castrioto</name><affiliation><mods:affiliation>CHU Grenoble, Unité des Troubles du Mouvement, Pôle de Psychiatrie et de Neurologie, La Tronche, France</mods:affiliation></affiliation></author><author><name sortKey="Vitello, N" sort="Vitello, N" uniqKey="Vitello N" first="N." last="Vitello">N. Vitello</name><affiliation><mods:affiliation>Clermont Université, Université d'Auvergne, CHU Clermont‐Ferrand, Service de Neurologie, CHU Gabriel Montpied, Clermont‐Ferrand, France</mods:affiliation></affiliation></author><author><name sortKey="Lemal, R" sort="Lemal, R" uniqKey="Lemal R" first="R." last="Lemal">R. Lemal</name><affiliation><mods:affiliation>Clermont Université, Université d'Auvergne, CHU Clermont‐Ferrand, Service d'Hématologie clinique adulte et de Thérapie cellulaire, CREaT‐EA 7283, INSERM CIC‐501, CHU Estaing, Clermont‐Ferrand, France</mods:affiliation></affiliation></author><author><name sortKey="Fraix, V" sort="Fraix, V" uniqKey="Fraix V" first="V." last="Fraix">V. Fraix</name><affiliation><mods:affiliation>CHU Grenoble, Unité des Troubles du Mouvement, Pôle de Psychiatrie et de Neurologie, La Tronche, France</mods:affiliation></affiliation></author><author><name sortKey="Krack, P" sort="Krack, P" uniqKey="Krack P" first="P." last="Krack">P. Krack</name><affiliation><mods:affiliation>CHU Grenoble, Unité des Troubles du Mouvement, Pôle de Psychiatrie et de Neurologie, La Tronche, France</mods:affiliation></affiliation></author><author><name sortKey="Durif, F" sort="Durif, F" uniqKey="Durif F" first="F." last="Durif">F. Durif</name><affiliation><mods:affiliation>Clermont Université, Université d'Auvergne, CHU Clermont‐Ferrand, Service de Neurologie, CHU Gabriel Montpied, Clermont‐Ferrand, France</mods:affiliation></affiliation><affiliation><mods:affiliation>E-mail: fdurif@chu-clermontferrand.fr</mods:affiliation></affiliation></author></analytic><monogr></monogr><series><title level="j">European Journal of Neurology</title><title level="j" type="abbrev">Eur J Neurol</title><idno type="ISSN">1351-5101</idno><idno type="eISSN">1468-1331</idno><imprint><publisher>Blackwell Publishing Ltd</publisher><date type="published" when="2013-07">2013-07</date><biblScope unit="volume">20</biblScope><biblScope unit="issue">7</biblScope><biblScope unit="page" from="92">e92</biblScope><biblScope unit="page" to="93">e93</biblScope></imprint><idno type="ISSN">1351-5101</idno></series><idno type="istex">DE52E18D4E1BCE34400449936B618278D795B35A</idno><idno type="DOI">10.1111/ene.12149</idno><idno type="ArticleID">ENE12149</idno></biblStruct></sourceDesc><seriesStmt><idno type="ISSN">1351-5101</idno></seriesStmt></fileDesc><profileDesc><textClass></textClass><langUsage><language ident="en">en</language></langUsage></profileDesc></teiHeader></TEI><istex><corpusName>wiley</corpusName><author><json:item><name>X. Moisset</name><affiliations><json:string>Clermont Université, Université d'Auvergne, CHU Clermont‐Ferrand, Service de Neurologie, CHU Gabriel Montpied, Clermont‐Ferrand, France</json:string></affiliations></json:item><json:item><name>A. Castrioto</name><affiliations><json:string>CHU Grenoble, Unité des Troubles du Mouvement, Pôle de Psychiatrie et de Neurologie, La Tronche, France</json:string></affiliations></json:item><json:item><name>N. Vitello</name><affiliations><json:string>Clermont Université, Université d'Auvergne, CHU Clermont‐Ferrand, Service de Neurologie, CHU Gabriel Montpied, Clermont‐Ferrand, France</json:string></affiliations></json:item><json:item><name>R. Lemal</name><affiliations><json:string>Clermont Université, Université d'Auvergne, CHU Clermont‐Ferrand, Service d'Hématologie clinique adulte et de Thérapie cellulaire, CREaT‐EA 7283, INSERM CIC‐501, CHU Estaing, Clermont‐Ferrand, France</json:string></affiliations></json:item><json:item><name>V. Fraix</name><affiliations><json:string>CHU Grenoble, Unité des Troubles du Mouvement, Pôle de Psychiatrie et de Neurologie, La Tronche, France</json:string></affiliations></json:item><json:item><name>P. Krack</name><affiliations><json:string>CHU Grenoble, Unité des Troubles du Mouvement, Pôle de Psychiatrie et de Neurologie, La Tronche, France</json:string></affiliations></json:item><json:item><name>F. Durif</name><affiliations><json:string>Clermont Université, Université d'Auvergne, CHU Clermont‐Ferrand, Service de Neurologie, CHU Gabriel Montpied, Clermont‐Ferrand, France</json:string><json:string>E-mail: fdurif@chu-clermontferrand.fr</json:string></affiliations></json:item></author><subject><json:item><lang><json:string>eng</json:string></lang><value>apomorphine</value></json:item><json:item><lang><json:string>eng</json:string></lang><value>eosinophilia</value></json:item><json:item><lang><json:string>eng</json:string></lang><value>idiopathic Parkinson's disease</value></json:item></subject><articleId><json:string>ENE12149</json:string></articleId><language><json:string>eng</json:string></language><originalGenre><json:string>letter</json:string></originalGenre><qualityIndicators><score>2.864</score><pdfVersion>1.7</pdfVersion><pdfPageSize>595.276 x 782.362 pts</pdfPageSize><refBibsNative>true</refBibsNative><abstractCharCount>0</abstractCharCount><pdfWordCount>852</pdfWordCount><pdfCharCount>6481</pdfCharCount><pdfPageCount>2</pdfPageCount><abstractWordCount>1</abstractWordCount></qualityIndicators><title>Major eosinophilia induced by subcutaneous apomorphine infusion: four cases</title><refBibs><json:item><author><json:item><name>A Bowron</name></json:item></author><host><volume>62</volume><pages><last>36</last><first>32</first></pages><issue>6 Suppl. 4</issue><author></author><title>Neurology</title></host><title>Practical considerations in the use of apomorphine injectable</title></json:item><json:item><author><json:item><name>D Deleu</name></json:item><json:item><name>Y Hanssens</name></json:item><json:item><name>MG Northway</name></json:item></author><host><volume>21</volume><pages><last>709</last><first>687</first></pages><author></author><title>Drugs Aging</title></host><title>Subcutaneous apomorphine: an evidence‐based review of its use in Parkinson's disease</title></json:item><json:item><author><json:item><name>FE Roufosse</name></json:item><json:item><name>M Goldman</name></json:item><json:item><name>E Cogan</name></json:item></author><host><volume>2</volume><pages><first>37</first></pages><author></author><title>Orphanet J Rare Dis</title></host><title>Hypereosinophilic syndromes</title></json:item><json:item><author><json:item><name>C Pot</name></json:item><json:item><name>R Oppliger</name></json:item><json:item><name>V Castillo</name></json:item><json:item><name>A Coeytaux</name></json:item><json:item><name>C Hauser</name></json:item><json:item><name>PR Burkhard</name></json:item></author><host><volume>64</volume><pages><last>393</last><first>392</first></pages><author></author><title>Neurology</title></host><title>Apomorphine‐induced eosinophilic panniculitis and hypereosinophilia in Parkinson disease</title></json:item><json:item><author><json:item><name>Z Podolec</name></json:item><json:item><name>J Vetulani</name></json:item><json:item><name>B Bednarczyk</name></json:item><json:item><name>A Szczeklik</name></json:item></author><host><volume>34</volume><pages><last>110</last><first>103</first></pages><author></author><title>Allergy</title></host><title>Central dopamine receptors regulate blood eosinophilia in the rat</title></json:item><json:item><author><json:item><name>G Choquet‐Kastylevsky</name></json:item><json:item><name>L Intrator</name></json:item><json:item><name>C Chenal</name></json:item><json:item><name>H Bocquet</name></json:item><json:item><name>J Revuz</name></json:item><json:item><name>JC Roujeau</name></json:item></author><host><volume>139</volume><pages><last>1032</last><first>1026</first></pages><author></author><title>Br J Dermatol</title></host><title>Increased levels of interleukin 5 are associated with the generation of eosinophilia in drug‐induced hypersensitivity syndrome</title></json:item></refBibs><genre><json:string>review-article</json:string></genre><host><volume>20</volume><publisherId><json:string>ENE</json:string></publisherId><pages><total>2</total><last>e93</last><first>e92</first></pages><issn><json:string>1351-5101</json:string></issn><issue>7</issue><subject><json:item><value>Letter to the Editor</value></json:item></subject><genre><json:string>journal</json:string></genre><language><json:string>unknown</json:string></language><eissn><json:string>1468-1331</json:string></eissn><title>European Journal of Neurology</title><doi><json:string>10.1111/(ISSN)1468-1331</json:string></doi></host><categories><wos><json:string>science</json:string><json:string>neurosciences</json:string><json:string>clinical neurology</json:string></wos><scienceMetrix><json:string>health sciences</json:string><json:string>clinical medicine</json:string><json:string>neurology & neurosurgery</json:string></scienceMetrix></categories><publicationDate>2013</publicationDate><copyrightDate>2013</copyrightDate><doi><json:string>10.1111/ene.12149</json:string></doi><id>DE52E18D4E1BCE34400449936B618278D795B35A</id><score>0.20391443</score><fulltext><json:item><extension>pdf</extension><original>true</original><mimetype>application/pdf</mimetype><uri>https://api.istex.fr/document/DE52E18D4E1BCE34400449936B618278D795B35A/fulltext/pdf</uri></json:item><json:item><extension>zip</extension><original>false</original><mimetype>application/zip</mimetype><uri>https://api.istex.fr/document/DE52E18D4E1BCE34400449936B618278D795B35A/fulltext/zip</uri></json:item><istex:fulltextTEI uri="https://api.istex.fr/document/DE52E18D4E1BCE34400449936B618278D795B35A/fulltext/tei"><teiHeader><fileDesc><titleStmt><title level="a" type="main" xml:lang="en">Major eosinophilia induced by subcutaneous apomorphine infusion: four cases</title></titleStmt><publicationStmt><authority>ISTEX</authority><publisher>Blackwell Publishing Ltd</publisher><availability><p>European Journal of Neurology © 2013 European Federation of Neurological Societies© 2013 The Author(s) European Journal of Neurology © 2013 EFNS</p></availability><date>2013-03-13</date></publicationStmt><sourceDesc><biblStruct type="inbook"><analytic><title level="a" type="main" xml:lang="en">Major eosinophilia induced by subcutaneous apomorphine infusion: four cases</title><author xml:id="author-1"><persName><forename type="first">X.</forename><surname>Moisset</surname></persName><affiliation>Clermont Université, Université d'Auvergne, CHU Clermont‐Ferrand, Service de Neurologie, CHU Gabriel Montpied, Clermont‐Ferrand, France</affiliation></author><author xml:id="author-2"><persName><forename type="first">A.</forename><surname>Castrioto</surname></persName><affiliation>CHU Grenoble, Unité des Troubles du Mouvement, Pôle de Psychiatrie et de Neurologie, La Tronche, France</affiliation></author><author xml:id="author-3"><persName><forename type="first">N.</forename><surname>Vitello</surname></persName><affiliation>Clermont Université, Université d'Auvergne, CHU Clermont‐Ferrand, Service de Neurologie, CHU Gabriel Montpied, Clermont‐Ferrand, France</affiliation></author><author xml:id="author-4"><persName><forename type="first">R.</forename><surname>Lemal</surname></persName><affiliation>Clermont Université, Université d'Auvergne, CHU Clermont‐Ferrand, Service d'Hématologie clinique adulte et de Thérapie cellulaire, CREaT‐EA 7283, INSERM CIC‐501, CHU Estaing, Clermont‐Ferrand, France</affiliation></author><author xml:id="author-5"><persName><forename type="first">V.</forename><surname>Fraix</surname></persName><affiliation>CHU Grenoble, Unité des Troubles du Mouvement, Pôle de Psychiatrie et de Neurologie, La Tronche, France</affiliation></author><author xml:id="author-6"><persName><forename type="first">P.</forename><surname>Krack</surname></persName><affiliation>CHU Grenoble, Unité des Troubles du Mouvement, Pôle de Psychiatrie et de Neurologie, La Tronche, France</affiliation></author><author xml:id="author-7"><persName><forename type="first">F.</forename><surname>Durif</surname></persName><email>fdurif@chu-clermontferrand.fr</email><affiliation>Clermont Université, Université d'Auvergne, CHU Clermont‐Ferrand, Service de Neurologie, CHU Gabriel Montpied, Clermont‐Ferrand, France</affiliation></author></analytic><monogr><title level="j">European Journal of Neurology</title><title level="j" type="abbrev">Eur J Neurol</title><idno type="pISSN">1351-5101</idno><idno type="eISSN">1468-1331</idno><idno type="DOI">10.1111/(ISSN)1468-1331</idno><imprint><publisher>Blackwell Publishing Ltd</publisher><date type="published" when="2013-07"></date><biblScope unit="volume">20</biblScope><biblScope unit="issue">7</biblScope><biblScope unit="page" from="92">e92</biblScope><biblScope unit="page" to="93">e93</biblScope></imprint></monogr><idno type="istex">DE52E18D4E1BCE34400449936B618278D795B35A</idno><idno type="DOI">10.1111/ene.12149</idno><idno type="ArticleID">ENE12149</idno></biblStruct></sourceDesc></fileDesc><profileDesc><creation><date>2013-03-13</date></creation><langUsage><language ident="en">en</language></langUsage><textClass><keywords scheme="keyword"><list><head>keywords</head><item><term>apomorphine</term></item><item><term>eosinophilia</term></item><item><term>idiopathic Parkinson's disease</term></item></list></keywords></textClass><textClass><keywords scheme="Journal Subject"><list><head>article-category</head><item><term>Letter to the Editor</term></item></list></keywords></textClass></profileDesc><revisionDesc><change when="2013-01-09">Received</change><change when="2013-02-14">Registration</change><change when="2013-03-13">Created</change><change when="2013-07">Published</change></revisionDesc></teiHeader></istex:fulltextTEI><json:item><extension>txt</extension><original>false</original><mimetype>text/plain</mimetype><uri>https://api.istex.fr/document/DE52E18D4E1BCE34400449936B618278D795B35A/fulltext/txt</uri></json:item></fulltext><metadata><istex:metadataXml wicri:clean="Wiley, elements deleted: body"><istex:xmlDeclaration>version="1.0" encoding="UTF-8" standalone="yes"</istex:xmlDeclaration><istex:document><component type="serialArticle" version="2.0" xml:id="ene12149" xml:lang="en"><header><publicationMeta level="product"><doi origin="wiley" registered="yes">10.1111/(ISSN)1468-1331</doi><issn type="print">1351-5101</issn><issn type="electronic">1468-1331</issn><idGroup><id type="product" value="ENE"></id></idGroup><titleGroup><title sort="EUROPEAN JOURNAL OF NEUROLOGY" type="main">European Journal of Neurology</title><title type="short">Eur J Neurol</title></titleGroup></publicationMeta><publicationMeta level="part" position="07107"><doi origin="wiley">10.1111/ene.2013.20.issue-7</doi><copyright ownership="thirdParty">European Journal of Neurology © 2013 European Federation of Neurological Societies</copyright><numberingGroup><numbering number="20" type="journalVolume">20</numbering><numbering type="journalIssue">7</numbering></numberingGroup><coverDate startDate="2013-07">July 2013</coverDate></publicationMeta><publicationMeta level="unit" position="19" status="forIssue" type="letter"><doi>10.1111/ene.12149</doi><idGroup><id type="unit" value="ENE12149"></id></idGroup><countGroup><count number="2" type="pageTotal"></count></countGroup><titleGroup><title type="articleCategory">Letter to the Editor</title><title type="tocHeading1">Letters to the Editor</title></titleGroup><copyright ownership="thirdParty">© 2013 The Author(s) European Journal of Neurology © 2013 EFNS</copyright><eventGroup><event date="2013-01-09" type="manuscriptReceived"></event><event date="2013-02-14" type="manuscriptAccepted"></event><event agent="SPS" date="2013-03-13" type="xmlCreated"></event><event type="firstOnline" date="2013-06-10"></event><event type="publishedOnlineFinalForm" date="2013-06-10"></event><event type="xmlConverted" agent="Converter:WILEY_ML3G_TO_WILEY_ML3GV2 version:3.8.8" date="2014-01-24"></event><event type="xmlConverted" agent="Converter:WML3G_To_WML3G version:4.6.4 mode:FullText" date="2015-10-01"></event></eventGroup><numberingGroup><numbering type="pageFirst">e92</numbering><numbering type="pageLast">e93</numbering></numberingGroup><correspondenceTo>Correspondence: F. Durif, Clermont Université, Université d'Auvergne; CHU Clermont‐Ferrand, Service de Neurologie; CHU Gabriel Montpied, Clermont‐Ferrand F‐63000, France (tel.: +33 4 73 75 22 00; fax: +33 4 73 75 22 06; e‐mail: <email>fdurif@chu-clermontferrand.fr</email>).</correspondenceTo><linkGroup><link type="toTypesetVersion" href="file:ENE.ENE12149.pdf"></link></linkGroup></publicationMeta><contentMeta><titleGroup><title type="main">Major eosinophilia induced by subcutaneous apomorphine infusion: four cases</title><title type="shortAuthors">Letter to the Editor</title></titleGroup><creators><creator affiliationRef="#ene12149-aff-0001" creatorRole="author" xml:id="ene12149-cr-0001"><personName><givenNames>X.</givenNames> <familyName>Moisset</familyName></personName></creator><creator affiliationRef="#ene12149-aff-0002" creatorRole="author" xml:id="ene12149-cr-0002"><personName><givenNames>A.</givenNames> <familyName>Castrioto</familyName></personName></creator><creator affiliationRef="#ene12149-aff-0001" creatorRole="author" xml:id="ene12149-cr-0003"><personName><givenNames>N.</givenNames> <familyName>Vitello</familyName></personName></creator><creator affiliationRef="#ene12149-aff-0003" creatorRole="author" xml:id="ene12149-cr-0004"><personName><givenNames>R.</givenNames> <familyName>Lemal</familyName></personName></creator><creator affiliationRef="#ene12149-aff-0002" creatorRole="author" xml:id="ene12149-cr-0005"><personName><givenNames>V.</givenNames> <familyName>Fraix</familyName></personName></creator><creator affiliationRef="#ene12149-aff-0002" creatorRole="author" xml:id="ene12149-cr-0006"><personName><givenNames>P.</givenNames> <familyName>Krack</familyName></personName></creator><creator affiliationRef="#ene12149-aff-0001" corresponding="yes" creatorRole="author" xml:id="ene12149-cr-0007"><personName><givenNames>F.</givenNames> <familyName>Durif</familyName></personName></creator></creators><affiliationGroup><affiliation type="organization" xml:id="ene12149-aff-0001"><orgName>Clermont Université, Université d'Auvergne, CHU Clermont‐Ferrand, Service de Neurologie, CHU Gabriel Montpied</orgName> <address><city>Clermont‐Ferrand</city><country>France</country></address></affiliation> <affiliation type="organization" xml:id="ene12149-aff-0002"><orgName>CHU Grenoble, Unité des Troubles du Mouvement, Pôle de Psychiatrie et de Neurologie</orgName> <address><city>La Tronche</city> <country>France</country></address></affiliation><affiliation countryCode="FR" type="organization" xml:id="ene12149-aff-0003"><orgName>Clermont Université, Université d'Auvergne, CHU Clermont‐Ferrand, Service d'Hématologie clinique adulte et de Thérapie cellulaire, CREaT‐EA 7283, INSERM CIC‐501, CHU Estaing</orgName> <address><city>Clermont‐Ferrand</city> <country>France</country></address></affiliation></affiliationGroup><keywordGroup type="author"><keyword xml:id="ene12149-kwd-0001">apomorphine</keyword><keyword xml:id="ene12149-kwd-0002">eosinophilia</keyword><keyword xml:id="ene12149-kwd-0003">idiopathic Parkinson's disease</keyword></keywordGroup></contentMeta></header></component></istex:document></istex:metadataXml><mods version="3.6"><titleInfo lang="en"><title>Major eosinophilia induced by subcutaneous apomorphine infusion: four cases</title></titleInfo><titleInfo type="alternative" contentType="CDATA" lang="en"><title>Major eosinophilia induced by subcutaneous apomorphine infusion: four cases</title></titleInfo><name type="personal"><namePart type="given">X.</namePart><namePart type="family">Moisset</namePart><affiliation>Clermont Université, Université d'Auvergne, CHU Clermont‐Ferrand, Service de Neurologie, CHU Gabriel Montpied, Clermont‐Ferrand, France</affiliation><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">A.</namePart><namePart type="family">Castrioto</namePart><affiliation>CHU Grenoble, Unité des Troubles du Mouvement, Pôle de Psychiatrie et de Neurologie, La Tronche, France</affiliation><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">N.</namePart><namePart type="family">Vitello</namePart><affiliation>Clermont Université, Université d'Auvergne, CHU Clermont‐Ferrand, Service de Neurologie, CHU Gabriel Montpied, Clermont‐Ferrand, France</affiliation><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">R.</namePart><namePart type="family">Lemal</namePart><affiliation>Clermont Université, Université d'Auvergne, CHU Clermont‐Ferrand, Service d'Hématologie clinique adulte et de Thérapie cellulaire, CREaT‐EA 7283, INSERM CIC‐501, CHU Estaing, Clermont‐Ferrand, France</affiliation><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">V.</namePart><namePart type="family">Fraix</namePart><affiliation>CHU Grenoble, Unité des Troubles du Mouvement, Pôle de Psychiatrie et de Neurologie, La Tronche, France</affiliation><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">P.</namePart><namePart type="family">Krack</namePart><affiliation>CHU Grenoble, Unité des Troubles du Mouvement, Pôle de Psychiatrie et de Neurologie, La Tronche, France</affiliation><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">F.</namePart><namePart type="family">Durif</namePart><affiliation>Clermont Université, Université d'Auvergne, CHU Clermont‐Ferrand, Service de Neurologie, CHU Gabriel Montpied, Clermont‐Ferrand, France</affiliation><affiliation>E-mail: fdurif@chu-clermontferrand.fr</affiliation><role><roleTerm type="text">author</roleTerm></role></name><typeOfResource>text</typeOfResource><genre type="review-article" displayLabel="letter"></genre><originInfo><publisher>Blackwell Publishing Ltd</publisher><dateIssued encoding="w3cdtf">2013-07</dateIssued><dateCreated encoding="w3cdtf">2013-03-13</dateCreated><dateCaptured encoding="w3cdtf">2013-01-09</dateCaptured><dateValid encoding="w3cdtf">2013-02-14</dateValid><copyrightDate encoding="w3cdtf">2013</copyrightDate></originInfo><language><languageTerm type="code" authority="rfc3066">en</languageTerm><languageTerm type="code" authority="iso639-2b">eng</languageTerm></language><physicalDescription><internetMediaType>text/html</internetMediaType></physicalDescription><subject><genre>keywords</genre><topic>apomorphine</topic><topic>eosinophilia</topic><topic>idiopathic Parkinson's disease</topic></subject><relatedItem type="host"><titleInfo><title>European Journal of Neurology</title></titleInfo><titleInfo type="abbreviated"><title>Eur J Neurol</title></titleInfo><genre type="journal">journal</genre><subject><genre>article-category</genre><topic>Letter to the Editor</topic></subject><identifier type="ISSN">1351-5101</identifier><identifier type="eISSN">1468-1331</identifier><identifier type="DOI">10.1111/(ISSN)1468-1331</identifier><identifier type="PublisherID">ENE</identifier><part><date>2013</date><detail type="volume"><caption>vol.</caption><number>20</number></detail><detail type="issue"><caption>no.</caption><number>7</number></detail><extent unit="pages"><start>e92</start><end>e93</end><total>2</total></extent></part></relatedItem><identifier type="istex">DE52E18D4E1BCE34400449936B618278D795B35A</identifier><identifier type="DOI">10.1111/ene.12149</identifier><identifier type="ArticleID">ENE12149</identifier><accessCondition type="use and reproduction" contentType="copyright">European Journal of Neurology © 2013 European Federation of Neurological Societies© 2013 The Author(s) European Journal of Neurology © 2013 EFNS</accessCondition><recordInfo><recordContentSource>WILEY</recordContentSource></recordInfo></mods></metadata><serie></serie></istex></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/ParkinsonFranceV1/Data/Istex/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000315 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Istex/Corpus/biblio.hfd -nk 000315 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Sante
|area= ParkinsonFranceV1
|flux= Istex
|étape= Corpus
|type= RBID
|clé= ISTEX:DE52E18D4E1BCE34400449936B618278D795B35A
|texte= Major eosinophilia induced by subcutaneous apomorphine infusion: four cases
}}
| This area was generated with Dilib version V0.6.29. |  |